Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement [Yahoo! Finance]
Intensity Therapeutics receives 180-day Nasdaq extension to regain compliance [Seeking Alpha]
Intensity Therapeutics Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
Intensity Therapeutics Announces Two Presentations at the Upcoming 2025 San Antonio Breast Cancer Symposium
Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update